SCHEMBL5378681

SCHEMBL5378681

CCc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(C(C)(C)C)cc3)cc2)cc1C(=O)OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.50
ALDH1A1 P00352 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
UQCRB P14927 1/20 0.50
PLAU P00749 4/20 0.49
HDAC3 O15379 2/20 0.49
HDAC11 Q96DB2 2/20 0.49
HDAC8 Q9BY41 2/20 0.49
HDAC6 Q9UBN7 2/20 0.49
UCHL1 P09936 1/20 0.49
PTPN5 P54829 1/20 0.48
LMNA P02545 2/20 0.48
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
RORA P35398 1/20 0.46
HIF1A Q16665 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5382304 0.90 MEN1 (0.55) MAPTMEN1KMT2APLAUHDAC3
SCHEMBL5378704 0.86 POLB (0.56) MAPTALDH1A1MEN1KMT2AUQCRB
SCHEMBL5370673 0.85 PLAU (0.52) MAPTPLAUHDAC3HDAC11HDAC8
SCHEMBL5373221 0.83 PTPN2 (0.63) MAPTALDH1A1MEN1KMT2APTPN5
SCHEMBL5371829 0.83 SMN1; SMN2 (0.52) ALDH1A1MEN1KMT2APLAUUCHL1
SCHEMBL5378743 0.83 UCHL1 (0.53) ALDH1A1PLAUUCHL1CYP1A2CYP3A4
SCHEMBL5378798 0.79 KDM1A (0.58) MAPTMEN1KMT2AHDAC3HDAC11
SCHEMBL4906225 0.78 NPSR1 (0.46) ALDH1A1MEN1KMT2ALMNACYP1A2
SCHEMBL5378765 0.77 POLB (0.65) MAPTALDH1A1MEN1KMT2AUQCRB
SCHEMBL5371871 0.76 MEN1 (0.57) MAPTMEN1KMT2APLAUPLAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MAPT 1786/4885ALDH1A1 2956/4885MEN1 4855/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD MAPT 1984/4885ALDH1A1 2752/4885MEN1 4861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.